Banyan Biomarkers, Inc.
New Filing
CIK: 0001581877·Biotechnology·DELAWARE·Filed: Jun 18, 2020
Total Offering
$2,965,419
Amount Sold
$2,265,419
Investors
8
First Sale
Dec 6, 2019
Offering Details
- Type
- Debt, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Henry Nordhoff | Related Person |
| Steven Richieri | Related Person |
| Ronald Hayes, PhD | Related Person |
| Herbert Boyer | Related Person |
| Nancy Denslow, PhD | Related Person |
| Stanford Warshawsky | Related Person |
| Andrew von Eschenbach, MD | Related Person |
| William Roper, Jr. | Related Person |
| Andrew Parker | Related Person |
Company
SEC Filing
0001581877-20-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free